|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 47/68 | |
| A61K 47/64 | |||
| A61K 47/65 | |||
| A61P 35/00 |
| (11) | Number of the document | 3185908 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15777735.0 |
| Date of filing the European patent application | 2015-08-14 | |
| (97) | Date of publication of the European application | 2017-07-05 |
| (45) | Date of publication and mention of the grant of the patent | 2020-04-15 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IB2015/056211 |
| Date | 2015-08-14 |
| (87) | Number | WO 2016/030791 |
| Date | 2016-03-03 |
| (30) | Number | Date | Country code |
| 201462042901 P | 2014-08-28 | US |
| (72) |
DUSHIN, Russell George, US
STROP, Pavel, US
DORYWALSKA, Magdalena Grazyna, US
MOINE, Ludivine, US
|
| (73) |
Rinat Neuroscience Corp.,
230 East Grand Avenue, South San Francisco, CA 94080,
US
Pfizer Inc., 235 East 42nd Street, New York, NY 10017, US |
| (54) | STABILITY-MODULATING LINKERS FOR USE WITH ANTIBODY DRUG CONJUGATES |
| STABILITY-MODULATING LINKERS FOR USE WITH ANTIBODY DRUG CONJUGATES |